Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Costs and Operating Expenses        
Cost of revenue, excluding depreciation 0 0 0 0
Research and development expenses, excluding depreciation 115,460 57,638 197,946 96,956
Selling, general and administrative expenses, excluding depreciation 55,152 44,625 110,773 100,252
Depreciation 2,892 2,083 5,570 4,207
Total costs and operating expenses 173,504 104,346 314,289 201,415
Loss from operations (173,504) (104,346) (314,289) (201,415)
Other income (expense)        
Interest income (expense) 19 34 (9) 46
Gain (loss) on fair value change in contingent earnout shares liability 9,471 (8,157) 24,936 75,402
Loss on fair value change in private placement warrants liability 0 0 0 (1,639)
Other (expense), net (378) (85) (395) (174)
Loss before income taxes (164,392) (112,554) (289,757) (127,780)
Provision for income taxes 0 0 0 0
Net loss and comprehensive loss (164,392) (112,554) (289,757) (127,780)
Net loss and comprehensive loss $ (164,392) $ (112,554) $ (289,757) $ (127,780)
Per Share Data:        
Net loss per share, basic (in dollars per share) $ (0.68) $ (0.50) $ (1.22) $ (0.57)
Net loss per share, diluted (in dollars per share) $ (0.68) $ (0.50) $ (1.22) $ (0.57)
Weighted-average shares outstanding, basic (in shares) 242,772 226,928 238,242 225,885
Weighted-average shares outstanding, diluted (in shares) 242,772 226,928 238,242 225,885